首页 > 市场调查报告书 > 製药

生技设备生物工艺

市场调查报告书

商品编码

1621141

生物工艺优化和数位生物製造：全球市场

Bioprocess Optimization and Digital Bio-manufacturing: Global Markets

出版日期: 2024年12月20日 | 出版商:

BCC Research | 英文 180 Pages | 订单完成后即时交付

价格

简介目录图表

全球生物製程优化和数位生物製造市场规模预计到 2029年终将达到 396 亿美元，预测期内复合年增长率为 10.2%，而 2024 年为 243 亿美元。

北美市场预计将从 2024 年的 90 亿美元成长到 2029年终的145 亿美元，预测期内复合年增长率为 10.0%。欧洲市场预计将从2024年的72亿美元成长到2029年终的115亿美元，复合年增长率为9.7%。

该报告调查了全球生物工艺优化和数位生物製造市场，提供市场概况、市场影响因素和市场机会分析、法律制度、新兴技术和技术发展趋势以及市场规模趋势- 编制预测、按各个类别进行详细分析和主要企业。

全球市场动态
市场驱动因素
人口老化加剧
慢性病增加
生物製药的需求正以前所未有的速度成长
产品发布数量增加
契约製造组织 (CMO) 的兴起
市场限制因素
缺乏技术纯熟劳工
设备成本高
智慧製造标准不统一
市场机会
有利的政府计划
感测器技术的进步
过程分析技术的倡议
市场挑战
技术问题和网路威胁
监管状况
良好自动化製造规范 (GAMP)
ISA（仪表、系统和自动化）协会：88/95 标准

第四章新兴科技与发展

新趋势和新技术
连续生物过程
连续细胞保留技术
连续层析法
免洗技术

第五章市场区隔分析

主要市场趋势
细分细分
市场分析：按技术
製造技术
分析与製程控制技术
软体
市场分析：依应用分类
生物製造过程的自动化和控制
柔性製造
生物过程优化和过程分析
其他的
市场分析：依分子类型
单株抗体 (mAb)
治疗性蛋白质和胜肽
疫苗
细胞和基因治疗
地域分布
市场分析：按地区
北美洲
欧洲
亚太地区
其他领域

第六章竞争讯息

主要企业排名
公司采取的主要策略
协作与伙伴关係
扩张
获得
新产品发布

第 7 章数位生物製造市场中的生物製程优化与永续性：ESG 视角

ESG：简介
产业ESG实践
环境绩效
社会表现
管治绩效
企业ESG风险评估
BCC的结语

第8章附录

调查方法
资讯来源
参考
简称
公司简介
AGILENT TECHNOLOGIES INC.
AGILITECH
BIO-RAD LABORATORIES INC.
BRUKER
CLEAN BIOLOGICS
DANAHER CORP.
EMERSON ELECTRIC CO.
EPPENDORF SE
KORBER AG
MERCK KGAA
SARTORIUS AG
SHIMADZU CORP.
THERMO FISHER SCIENTIFIC INC.
UNIVERCELLS TECHNOLOGIES
WATERS CORP.

简介目录图表

Product Code: BIO170B

The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.

The North American bioprocess optimization and digital biomanufacturing market is expected to grow from $9.0 billion in 2024 and is projected to reach $14.5 billion by the end of 2029, at a CAGR of 10.0% during the forecast period of 2024 to 2029.

The European bioprocess optimization and digital biomanufacturing market is expected to grow from $7.2 billion in 2024 and is projected to reach $11.5 billion by the end of 2029, at a CAGR of 9.7% during the forecast period of 2024 to 2029.

Report Scope

The report provides a comprehensive analysis of the bioprocess optimization and digital biomanufacturing market in a global context, including market forecasts and sales through the year 2029. Segmentation based on technology type includes manufacturing technologies (chromatography-based separation and purification, filtration, bioreactors, centrifugation), analytical and process control technologies (spectrophotometry, automation and industrial process control technologies, analytical chromatography, sensors and probes), and software (Industrial control and automation software, bioprocess optimization and data analytics software). Segmentation based on application includes biomanufacturing process automation and control, flexible manufacturing, bioprocess optimization and process analytics, and others. By molecule type the market is segmented into monoclonal antibodies, vaccines, therapeutic proteins and peptides, and cell and gene therapies. The regional markets covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

The report discusses the critical issues impacting the adoption of digital biomanufacturing in pharmaceuticals, as well as emerging trends in digital biomanufacturing technologies. It also features new developments and new product launches in the global market. The report provides comprehensive profiles of market players in the industry. The report also covers mergers and acquisitions and any other collaborations or partnerships that occurred during the evaluation period of this report and which are expected to shape the industry.

Report Includes

69 data tables and 61 additional tables
Analyses of trends in the global market for bioprocess optimization and digital bio-manufacturing, with market revenue data for 2021-2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
Estimates of the market size and revenue growth prospects of the global market, along with a market share analysis by technology, application, drug molecule type and region
Facts and figures pertaining to the market dynamics, technical advances, regulations and the impact of macroeconomic factors
Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
Analysis of patents, emerging trends, and new developments
Analysis of the industry structure, including companies' market shares, strategic alliances, M&A activity and a venture funding outlook
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and ESG scores and practices of leading companies
Profiles of the market leaders, including Agilent Technologies Inc., Thermo Fisher Scientific Inc., Danaher Corp., and Sartorius AG.

Chapter 1 Introduction

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
Technology Background
Biologics Manufacturing Process
Upstream Processing
Cell Harvesting and Clarification
Downstream Processing
Bioprocess Optimization
Industry 4.0-Digital Biomanufacturing

Chapter 3 Market Dynamics

Global Market Dynamics
Market Drivers
Growing Aging Population
Increasing Prevalence of Chronic Diseases
Unprecedented Rise in Demand for Biopharmaceuticals
Growing Number of Product Launches
Increasing Number of Contract Manufacturing Organizations (CMOs)
Market Restraints
Lack of Skilled Labor
High Cost of Equipment
Unharmonized Smart Manufacturing Standards
Market Opportunities
Favorable Government Programs
Advances in Sensor Technology
Process Analytical Technology Initiatives
Market Challenges
Technical Issues and the Threat of Cyberattacks
Regulatory Landscape
Good Automation Manufacturing Practices (GAMP)
Instrumentation, Systems, and Automation (ISA) Society-88 and 95 Standards

Chapter 4 Emerging Technologies and Developments

Emerging Trends and Technologies
Continuous Bioprocessing
Continuous Cell Retention Technologies
Continuous Chromatography
Single-Use Technologies

Chapter 5 Market Segmentation Analysis

Key Market Trends
Segmentation Breakdown
Market Analysis by Technology
Manufacturing Technologies
Analytical and Process Control Technologies
Software
Market Analysis by Application
Biomanufacturing Process Automation and Control
Flexible Manufacturing
Bioprocess Optimization and Process Analytics
Other Applications
Market Analysis by Molecule Type
Monoclonal Antibodies (mAbs)
Therapeutic Proteins and Peptides
Vaccines
Cell and Gene Therapies
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence

Ranking of Leading Players
Key Strategies Adopted by Players
Collaborations and Partnerships
Expansion
Acquisitions
New Product Launches

Chapter 7 Sustainability in the Bioprocess Optimization and Digital Biomanufacturing Market: An ESG Perspective

Introduction to ESG
ESG Practices in the Industry
Environmental Performance
Social Performance
Governance Performance
Companies' ESG Risk Ratings
Concluding Remarks from BCC Research

Chapter 8 Appendix

Methodology
Information Sources
References
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
AGILITECH
BIO-RAD LABORATORIES INC.
BRUKER
CLEAN BIOLOGICS
DANAHER CORP.
EMERSON ELECTRIC CO.
EPPENDORF SE
KORBER AG
MERCK KGAA
SARTORIUS AG
SHIMADZU CORP.
THERMO FISHER SCIENTIFIC INC.
UNIVERCELLS TECHNOLOGIES
WATERS CORP.

简介目录图表

List of Tables

Summary Table A : Global Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, Through 2029
Summary Table B : Global Market for Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 1 : List of Biologics Produced in E. coli
Table 2 : List of Biologics Produced in Mammalian Cells
Table 3 : Number and Distribution of Persons Aged 60+, by Region, 2019 and 2050
Table 4 : Global Cancer Incidence and Mortality Cases, by WHO Region, 2022
Table 5 : Medicine Regulators and Biosimilar Approvals, 2024
Table 6 : List of Regulatory Guidelines Related to Biopharmaceutical Manufacturing, 2024
Table 7 : Examples of Continuous Processing Developments
Table 8 : Global Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, Through 2029
Table 9 : Global Market for Manufacturing Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Type, Through 2029
Table 10 : Global Market for Manufacturing Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 11 : Global Market for Chromatography-based Separation and Purification Technology in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 12 : Global Market for Filtration Technology in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 13 : Global Market for Bioreactor Technology in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 14 : Global Market for Centrifugation Technology in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 15 : Global Market for Analytical and Process Control Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Type, Through 2029
Table 16 : Global Market for Analytical and Process Control Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 17 : Global Market for Spectrophotometry in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 18 : Global Market for Automation and Industrial Process Control Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Region Through 2029
Table 19 : Global Market for Analytical Chromatography in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 20 : Global Market for Sensors and Probes in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 21 : Global Market for Software in Bioprocess Optimization and Digital Biomanufacturing, by Type, Through 2029
Table 22 : Global Market for Software in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 23 : Global Market for Industrial Control and Automation Software in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 24 : Global Market for Bioprocess Optimization and Data Analytics Software in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 25 : Global Market for Other Software Types in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 26 : Global Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, Through 2029
Table 27 : Global Market for Biomanufacturing Process Automation and Control Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 28 : Global Market for Flexible Manufacturing Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 29 : Global Market for Bioprocess Optimization and Process Analytics Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 30 : Global Market for Other Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 31 : Global Market for Bioprocess Optimization and Digital Biomanufacturing , by Molecule Type, Through 2029
Table 32 : Global Market of Monoclonal Antibodies in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 33 : Global Market for Therapeutic Proteins and Peptides in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 34 : Global Market for Vaccines in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 35 : Global Market for Cell and Gene Therapies in Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 36 : Global Market for Bioprocess Optimization and Digital Biomanufacturing, by Region, Through 2029
Table 37 : North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, Through 2029
Table 38 : North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, Through 2029
Table 39 : North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, Through 2029
Table 40 : North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Software, Through 2029
Table 41 : North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, Through 2029
Table 42 : North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, Through 2029
Table 43 : European Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, Through 2029
Table 44 : European Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, Through 2029
Table 45 : European Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, Through 2029
Table 46 : European Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Software, Through 2029
Table 47 : European Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, Through 2029
Table 48 : European Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, Through 2029
Table 49 : Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, Through 2029
Table 50 : Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, Through 2029
Table 51 : Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, Through 2029
Table 52 : Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Software, Through 2029
Table 53 : Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, Through 2029
Table 54 : Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, Through 2029
Table 55 : RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, Through 2029
Table 56 : RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, Through 2029
Table 57 : RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, Through 2029
Table 58 : RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of for Software, Through 2029
Table 59 : RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, Through 2029
Table 60 : RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, Through 2029
Table 61 : Ranking of Leading Players in the Bioprocess Optimization and Digital Biomanufacturing Market, 2023
Table 62 : Collaborations and Partnerships: Bioprocess Optimization and Digital Biomanufacturing Market, 2021-2024
Table 63 : Expansion: Bioprocess Optimization and Digital Biomanufacturing Market, 2020-2024
Table 64 : Acquisitions: Bioprocess Optimization and Digital Biomanufacturing Market, 2020-2024
Table 65 : New Product Launches: Bioprocess Optimization and Digital Biomanufacturing Market, 2022-2024
Table 66 : Key Focus Areas in ESG Metrics
Table 67 : Environmental Performance Initiatives in the Bioprocess Optimization and Digital Biomanufacturing Market
Table 68 : Social Performance Initiatives in the Bioprocess Optimization and Digital Biomanufacturing Market
Table 69 : Governance Performance Initiatives in the Bioprocess Optimization and Digital Biomanufacturing Market
Table 70 : ESG Rankings for Key Players in the Bioprocess Optimization and Digital Biomanufacturing Market, 2024*
Table 71 : Abbreviations Used in this Report
Table 72 : Agilent Technologies Inc.: Company Snapshot
Table 73 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 74 : Agilent Technologies Inc.: Product & Services Portfolio
Table 75 : Agilent Technologies Inc.: News/Key Developments, 2022-2024
Table 76 : Agilitech: Company Snapshot
Table 77 : Agilitech: Product Portfolio
Table 78 : Agilitech: News/Key Developments, 2022 and 2024
Table 79 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 80 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 81 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 82 : Bio-Rad Laboratories Inc.: News/Key Developments,2022
Table 83 : Bruker: Company Snapshot
Table 84 : Bruker: Financial Performance, FY 2022 and 2023
Table 85 : Bruker: Product Portfolio
Table 86 : Bruker: News/Key Developments, 2022 and 2023
Table 87 : Clean Biologics: Company Snapshot
Table 88 : Clean Biologics: Product & Services Portfolio
Table 89 : Clean Biologics: News/Key Developments, 2021-2023
Table 90 : Danaher Corp.: Company Snapshot
Table 91 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 92 : Danaher Corp.: Product Portfolio
Table 93 : Danaher Corp.: News/Key Developments, 2023
Table 94 : Emerson Electric Co.: Company Snapshot
Table 95 : Emerson Electric Co.: Financial Performance, FY 2022 and 2023
Table 96 : Emerson Electric Co.: Product Portfolio
Table 97 : Emerson Electric Co.: News/Key Developments, 2022-2024
Table 98 : Eppendorf SE: Company Snapshot
Table 99 : Eppendorf SE: Financial Performance, FY 2022 and 2023
Table 100 : Eppendorf SE: Product Portfolio
Table 101 : Eppendorf SE: News/Key Developments, 2022-2024
Table 102 : Korber AG: Company Snapshot
Table 103 : Korber AG: Financial Performance, FY 2022 and 2023
Table 104 : Korber AG: Product Portfolio
Table 105 : Korber AG: News/Key Developments, 2024
Table 106 : Merck KGaA: Company Snapshot
Table 107 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 108 : Merck KGaA: Product Portfolio
Table 109 : Merck KGaA: News/Key Developments, 2024
Table 110 : Sartorius AG: Company Snapshot
Table 111 : Sartorius AG: Financial Performance, FY 2022 and 2023
Table 112 : Sartorius AG: Product Portfolio
Table 113 : Sartorius AG: News/Key Developments, 2021-2024
Table 114 : Shimadzu Corp.: Company Snapshot
Table 115 : Shimadzu Corp.: Financial Performance, FY 2022 and 2023
Table 116 : Shimadzu Corp.: Product Portfolio
Table 117 : Shimadzu Corp.: News/Key Developments, 2024
Table 118 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 119 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 120 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 121 : Thermo Fisher Scientific Inc.: News/Key Developments, 2020-2022
Table 122 : Univercells Technologies: Company Snapshot
Table 123 : Univercells Technologies: Product Portfolio
Table 124 : Univercells Technologies: News/Key Developments, 2024
Table 125 : Waters Corp.: Company Snapshot
Table 126 : Waters Corp.: Financial Performance, FY 2022 and 2023
Table 127 : Waters Corp.: Product Portfolio
Table 128 : Waters Corp.: News/Key Developments, 2021-2023

List of Figures

Summary Figure A : Global Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, 2021-2029
Summary Figure B : Global Market for Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 1 : A Typical Biopharmaceutical Manufacturing Process
Figure 2 : Market Dynamics for Bioprocess Optimization and Digital Biomanufacturing
Figure 3 : Global Market Share for Bioprocess Optimization and Digital Biomanufacturing, by Technology, 2024
Figure 4 : Global Market for Manufacturing Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Type, 2021-2029
Figure 5 : Global Market for Manufacturing Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 6 : Global Market for Chromatography-based Separation and Purification Technology in Bioprocess Optimization and Digital Biomanufacturing , by Region, 2021-2029
Figure 7 : Global Market for Filtration Technology in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 8 : Global Market for Bioreactor Technology in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 9 : Global Market for Centrifugation Technology in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 10 : Global Market for Analytical and Process Control Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Type, 2021-2029
Figure 11 : Global Market for Analytical and Process Control Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 12 : Global Market for Spectrophotometry in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 13 : Global Market for Automation and Industrial Process Control Technologies in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 14 : Global Market for Analytical Chromatography in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 15 : Global Market for Sensors and Probes in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 16 : Global Market for Software in Bioprocess Optimization and Digital Biomanufacturing, by Type, 2021-2029
Figure 17 : Global Market for Software in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 18 : Global Market for Industrial Control and Automation Software in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 19 : Global Market for Bioprocess Optimization and Data Analytics Software in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 20 : Global Market for Other Software Types in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 21 : Global Market Share for Bioprocess Optimization and Digital Biomanufacturing, by Application, 2024
Figure 22 : Global Market for Biomanufacturing Process Automation and Control Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 23 : Global Market for Flexible Manufacturing Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 24 : Global Market for Bioprocess Optimization and Process Analytics Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 25 : Global Market for Other Applications in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 26 : Global Market Share for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, 2024
Figure 27 : Global Market of Monoclonal Antibodies in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 28 : Global Market for Therapeutic Proteins and Peptides in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 29 : Global Market for Vaccines in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 30 : Global Market for Cell and Gene Therapies in Bioprocess Optimization and Digital Biomanufacturing, by Region, 2021-2029
Figure 31 : Global Market Share for Bioprocess Optimization and Digital Biomanufacturing, by Region, 2024
Figure 32 : North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, 2021-2029
Figure 33 : North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, 2021-2029
Figure 34 : North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, 2021-2029
Figure 35 : North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Software, 2021-2029
Figure 36 : North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, 2021-2029
Figure 37 : North American Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, 2021-2029
Figure 38 : European Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, 2021-2029
Figure 39 : European Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, 2021-2029
Figure 40 : European Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, 2021-2029
Figure 41 : European Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Software, 2021-2029
Figure 42 : European Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, 2021-2029
Figure 43 : European Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, 2021-2029
Figure 44 : Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, 2021-2029
Figure 45 : Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, 2021-2029
Figure 46 : Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, 2021-2029
Figure 47 : Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Software, 2021-2029
Figure 48 : Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, 2021-2029
Figure 49 : Asia-Pacific Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, 2021-2029
Figure 50 : RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Technology, 2021-2029
Figure 51 : RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Manufacturing Technology, 2021-2029
Figure 52 : RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Analytical and Process Control Technology, 2021-2029
Figure 53 : RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Type of Software, 2021-2029
Figure 54 : RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Application, 2021-2029
Figure 55 : RoW Market for Bioprocess Optimization and Digital Biomanufacturing, by Molecule Type, 2021-2029
Figure 56 : Global Market Share for Bioprocess Optimization and Digital Biomanufacturing, by Key Strategies Adopted, 2020 to 2024
Figure 57 : How a Strong ESG Proposition Benefits Businesses
Figure 58 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 59 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 60 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 61 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 62 : Bruker: Revenue Share, by Business Unit, FY 2023
Figure 63 : Bruker: Revenue Share, by Country/Region, FY 2023
Figure 64 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 65 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 66 : Emerson Electric Co.: Revenue Share, by Business Unit, FY 2023
Figure 67 : Emerson Electric Co.: Revenue Share, by Country/Region, FY 2023
Figure 68 : Eppendorf SE: Revenue Share, by Business Unit, FY 2023
Figure 69 : Eppendorf SE: Revenue Share, by Country/Region, FY 2023
Figure 70 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 71 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 72 : Sartorius AG: Revenue Share, by Business Unit, FY 2023
Figure 73 : Sartorius AG: Revenue Share, by Country/Region, FY 2023
Figure 74 : Shimadzu Corp.: Revenue Share, by Business Unit, FY 2023
Figure 75 : Shimadzu Corp.: Revenue Share, by Country/Region, FY 2023
Figure 76 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 77 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
Figure 78 : Waters Corp.: Revenue Share, by Business Unit, FY 2023
Figure 79 : Waters Corp.: Revenue Share, by Country/Region, FY 2023